MedPath

Testosterone

Generic Name
Testosterone
Brand Names
Androderm, Androgel, Axiron, Fortesta, Natesto, Striant, Testim, Testopel, Vogelxo
Drug Type
Small Molecule
Chemical Formula
C19H28O2
CAS Number
58-22-0
Unique Ingredient Identifier
3XMK78S47O

Overview

Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics. Testosterone was isolated from samples and also synthesized in 1935.

Background

Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics. Testosterone was isolated from samples and also synthesized in 1935.

Indication

Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.

Associated Conditions

  • Hypergonadotropic Hypogonadism
  • Hypogonadotrophic Hypogonadism
  • Idiopathic Hypogonadotropic Hypogonadism
  • Puberty, Delayed
  • Inoperable, metastatic Breast cancer

FDA Approved Products

Testosterone
Manufacturer:Actavis Pharma, Inc.
Route:TRANSDERMAL
Strength:16.2 mg in 1 g
Approved: 2021/02/12
NDC:0591-2924
Testopel
Manufacturer:Slate Pharma
Route:SUBCUTANEOUS
Strength:75 mg in 1 1
Approved: 2013/06/27
NDC:43773-1001
Testosterone
Manufacturer:REMEDYREPACK INC.
Route:TOPICAL
Strength:12.5 mg in 1.25 g
Approved: 2018/05/14
NDC:70518-1171
Testosterone
Manufacturer:Lupin Pharmaceuticals, Inc.
Route:TRANSDERMAL
Strength:16.2 mg in 1 g
Approved: 2019/08/01
NDC:68180-941
Androgel
Manufacturer:Physicians Total Care, Inc.
Route:TRANSDERMAL
Strength:10 mg in 1 g
Approved: 2011/12/15
NDC:54868-4810

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath